ES2103486T3 - Medicamentos que contienen acidos difosfonicos y sus sales. - Google Patents

Medicamentos que contienen acidos difosfonicos y sus sales.

Info

Publication number
ES2103486T3
ES2103486T3 ES93919101T ES93919101T ES2103486T3 ES 2103486 T3 ES2103486 T3 ES 2103486T3 ES 93919101 T ES93919101 T ES 93919101T ES 93919101 T ES93919101 T ES 93919101T ES 2103486 T3 ES2103486 T3 ES 2103486T3
Authority
ES
Spain
Prior art keywords
salts
drugs containing
diphosphonic acids
containing diphosphonic
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93919101T
Other languages
English (en)
Inventor
Gerhard Winter
Bernhard Pichler
Heinrich Woog
Werner Heller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6466588&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2103486(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Application granted granted Critical
Publication of ES2103486T3 publication Critical patent/ES2103486T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA INVENCION SE REFIERE A PREPARACIONES FARMACEUTICAS ESTABLES AL ALMACENAMIENTO, QUE CONTIENEN COMO SUSTANCIA ACTIVA AL MENOS UN ACIDO DIFOSFONICO Y/O AL MENOS UNA SAL INOFENSIVA FISIOLOGICAMENTE DE LOS MENCIONADOS ACIDOS.
ES93919101T 1992-08-27 1993-08-19 Medicamentos que contienen acidos difosfonicos y sus sales. Expired - Lifetime ES2103486T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4228552A DE4228552A1 (de) 1992-08-27 1992-08-27 Diphosphonsäuren und deren Salze enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ES2103486T3 true ES2103486T3 (es) 1997-09-16

Family

ID=6466588

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93919101T Expired - Lifetime ES2103486T3 (es) 1992-08-27 1993-08-19 Medicamentos que contienen acidos difosfonicos y sus sales.

Country Status (11)

Country Link
US (1) US5662918A (es)
EP (1) EP0656780B1 (es)
JP (1) JP3118258B2 (es)
AT (1) ATE151636T1 (es)
AU (1) AU4949993A (es)
CA (1) CA2141964C (es)
DE (2) DE4228552A1 (es)
DK (1) DK0656780T3 (es)
ES (1) ES2103486T3 (es)
GR (1) GR3023962T3 (es)
WO (1) WO1994005297A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0998932A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
US5932563A (en) * 1998-10-23 1999-08-03 Ohio State Research Foundation Methods for treating spinal cord injury
US6794536B1 (en) * 1998-12-10 2004-09-21 Aesqen, Inc. Method for preparation of disodium pamidronate
BR0110618A (pt) * 2000-05-05 2003-04-29 Hoffmann La Roche Composição farmacêutica similar a gel para administraçâo subcutânea compreendendo ácidos bis-fosfÈnicos ou seus sais
US20040082545A1 (en) * 2000-09-18 2004-04-29 Handreck Gregory Paul Diphosphonate solutions
CA2347330C (en) * 2001-05-10 2002-03-12 Pharmaceutical Partners Of Canada Inc. Liquid injectable formulation of disodium pamidronate
WO2006100687A1 (en) * 2005-03-24 2006-09-28 Dabur Pharma Ltd. Disodium pamidronate aqueous formulation
US20070191315A1 (en) * 2006-02-16 2007-08-16 Bengt Bergstrom Method for administering ibandronate
EP2363111A1 (en) 2010-03-01 2011-09-07 Combino Pharm, S.L. Stable pharmaceutical composition comprising bisphosphonate
CN102770122B (zh) * 2010-04-16 2013-12-11 台湾东洋药品工业股份有限公司 双磷酸注射液医药产品及其制法
WO2012048285A1 (en) * 2010-10-08 2012-04-12 Lanco Biosciences, Inc. Delivery of bisphosphonates by microinjection systems
IT201600123773A1 (it) * 2016-12-06 2018-06-06 Abiogen Pharma Spa Composizione per il trattamento dell’osteoartrosi
TW202344238A (zh) * 2022-01-28 2023-11-16 美商拜耳保健有限責任公司 經硫酸銨處理以提升醫藥組成物之穩定性的注射器

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2217692C3 (de) * 1972-04-13 1984-10-18 Henkel KGaA, 4000 Düsseldorf Komplexbildner mit mehrwertigen Metallionen
DE3370443D1 (en) * 1982-06-10 1987-04-30 Mallinckrodt Inc Radiographic imaging agents
DE3225469A1 (de) * 1982-07-05 1984-01-05 Schering AG, 1000 Berlin und 4709 Bergkamen Diphosphonsaeure-derivate und diese enthaltende pharmazeutische praeparate
DE3428524A1 (de) * 1984-08-02 1986-02-13 Boehringer Mannheim Gmbh, 6800 Mannheim Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4902679A (en) * 1985-12-13 1990-02-20 Norwich Eaton Pharmaceuticals, Inc. Methods of treating diseases with certain geminal diphosphonates
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
SU1742242A1 (ru) * 1990-07-31 1992-06-23 Львовский политехнический институт им.Ленинского комсомола Способ термохимической обработки полых стеклоизделий

Also Published As

Publication number Publication date
JPH08500830A (ja) 1996-01-30
WO1994005297A1 (de) 1994-03-17
AU4949993A (en) 1994-03-29
DK0656780T3 (da) 1997-10-27
EP0656780A1 (de) 1995-06-14
JP3118258B2 (ja) 2000-12-18
US5662918A (en) 1997-09-02
CA2141964C (en) 2003-10-21
DE4228552A1 (de) 1994-03-03
CA2141964A1 (en) 1994-03-17
DE59306211D1 (de) 1997-05-22
GR3023962T3 (en) 1997-09-30
ATE151636T1 (de) 1997-05-15
EP0656780B1 (de) 1997-04-16

Similar Documents

Publication Publication Date Title
ES2103486T3 (es) Medicamentos que contienen acidos difosfonicos y sus sales.
NO843002L (no) Vandig loesning inneholdende en lipid-loeselig farmasoeytisk substans
CO4750836A1 (es) Nuevos medicamentos y utilizacion (1-metiletil)-8-azoniabiciclo-[3.2.1]octnao y su uso en pre- paraciones medicas
DE3579128D1 (de) 13-cis-vitamin-a-saeure als wirksubstanz enthaltende arzneimittel.
ES2040727T3 (es) Un proceso para preparar una formulacion en aerosol en solucion de un analogo.
DE3669104D1 (de) Pharmazeutische praeparate, die ascorbinsaeurederivate enthalten.
DE3863678D1 (de) Lithiumsalze enthaltende pharmazeutische zubereitungen.
NL192561B (nl) Oogontstekings-werende middelen. Oftalmische preparaten die bepaalde fenylazijnzuurverbindingen bevatten.
DK644388D0 (da) Farmaceutiske praeparater indeholdende 3-hydroxy-smoeresyrederivater
SV1998000119A (es) Formulacion medicamentosa con liberacion controlada de sustancia activa. ref. lea 32671-sv
DE58905681D1 (de) Pharmazeutische Präparate zur verbesserten Resorption antibakterieller Verbindungen.
PA8451701A1 (es) Formulacion inyectable transparente de compuesto anestesico
UY26371A1 (es) Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen
ES2065313T3 (es) Tableta con biodisponibilidad mejorada que contiene acido diclorometilendifosfonico como sustancia activa.
FR2598320B1 (fr) Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques
NO883500D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk aktivt nitrometan.
ES2043696T3 (es) Derivados de prostaglandina e1 (derivados-pge1) como substancias activas farmaceuticas y medicamentos que contienen estos compuestos, especialmente para aplicacion transcutanea.
MX9301746A (es) Nuevos acidos 9-fluor-7-oxo-7h-pirido(1,2,3,-de)(1,4)-benzoxacin-6-carboxilicos y sus esteres, procedimiento para su preparacion y medicamentos que los contienen.
AR247327A1 (es) Una composicion herbicida
ES2043943T3 (es) Procedimiento para la preparacion de compuestos con actividad analgesica central.
SE8501518D0 (sv) Pharmazeutische preparate
IT7921652A0 (it) Preparato farmaceutico contenente un derivato di acido orto-amminobenzoico come imgrediente attivo.
ES2122962T3 (es) Derivados de alquileno-dioxibenceno opticamente activos y su uso en terapia.
DE69101220T2 (de) Öliges ketoprofen enthaltende kapsel.
MX9302929A (es) Derivados de tetrahidro y perhidroisoquinolina y medios terapeuticos que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 656780

Country of ref document: ES